AVM Biotechnology Provides a Solution to Needed Innovation for Cancer Cures

AVM Biotechnology, a National Cancer Institute 2023 Showcase Company, gave an invited presentation at BIO Investor Forum 2023, highlighting how AVM0703 targets a unique mechanism of action additive/synergistic with other therapies.